Have a personal or library account? Click to login
Indoor Exposure to Mould Allergens Cover

References

  1. Stetzenbach LD, Buttner MP, Cruz P. Detection and enumeration of airborne biocontaminants. Curr Opin Biotechnol 2004;15:170-4.10.1016/j.copbio.2004.04.009
  2. Shelton BG, Kirkland KH, Flanders WD, Morris GK. Profiles of airborne fungi in buildings and outdoor environments in the United States. App Environ Microbiol 2002;68:1743-53.10.1128/AEM.68.4.1743-1753.2002
  3. Górny RL, Dutkiewicz J. Bacterial and fungal aerosols in indoor environment in Central and Eastern European countries. Ann Agric Environ Med 2002;9:17-23.
  4. Jo WK, Seo YJ. Indoor and outdoor bioaerosol levels at recreation facilities, elementary schools, and homes. Chemosphere 2005;61:1570-9.10.1016/j.chemosphere.2005.04.103
  5. Bartlett KH, Kennedy SM, Brauer M, van Netten C, Dill B. Evaluation and a predictive model of airborne fungal concentrations in school classrooms. Ann Occup Hyg 2004;48:547-54.
  6. Šegvić Klarić M, Pepeljnjak S. A year-round aeromycological study in Zagreb area, Croatia. Ann Agric Environ Med 2006;13:55-64.
  7. Ianovici N, Tudorica D. Aeromycoflora in outdoor environment of Timisoara city (Romania). Not Sci Biol 2009;1:21-8.10.15835/nsb113446
  8. Peternel R, Čulig J, Hrga I. Atmospheric concentrations of Cladosporium spp. and Alternaria spp. spores in Zagreb (Croatia) and effects of some meteorological factors. Ann Agric Environ Med 2004;11:303-7.
  9. Pulimood TB, Corden JM, Bryden C, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 2007;120:610-7.10.1016/j.jaci.2007.04.045
  10. Cabral JPS. Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions. Sci Total Environ 2010;408:4285-95.10.1016/j.scitotenv.2010.07.005
  11. Fischer G, Dott W. Relevance of airborne fungi and their secondary metabolites for environmental, occupational and indoor hygiene. Arch Microbiol 2003;179:75-82.10.1007/s00203-002-0495-2
  12. Horner WE, Worthan AG, Morey PR. Air- and dustborne mycoflora in houses free of water damage and fungal growth. App Environ Microbiol 2004;70:6394-400.10.1128/AEM.70.11.6394-6400.2004
  13. Pei-Chih W, Huey-Jen S, Chia-Yin L. Characteristics of indoor and outdoor airborne fungi at suburban and urban homes in two seasons. Sci Total Environ 2000;253:111-8.10.1016/S0048-9697(00)00423-X
  14. Jacob B, Ritz B, Gehring U, Koch A, Bischof W, Wichmann HE. Indoor exposure to mold and allergic sensitization. Environ Health Perspect 2002;110:647-53.10.1289/ehp.02110647124091012117641
  15. Vesper S, McKinstry C, Haugland R, Neas L, Hudgens E, Heidenfelder B, Gallagher J. Higher environmental relative moldiness index (ERMIsm) values measured in Detroit homes of severely asthmatic children. Sci Total Environ 2008;394:192-6.10.1016/j.scitotenv.2008.01.03118280542
  16. Su HJ, Wu PC, Chen HL, Lee FC, Lin LL. Exposure assessment of indoor allergens, endotoxin, and airborne fungi for homes in Southern Taiwan. Environ Res 2001;85:135-44.10.1006/enrs.2000.411311161663
  17. Liang Y, Zhao W, Xu J, Miller JD. Characterization of two related exoantigens from the biodeteriogenic fungus Aspergillus versicolor. Int Biodeter Biodeg 2011;65:217-26.10.1016/j.ibiod.2010.11.005
  18. Chew GL, Wilson J, Rabito FA, Grimsley F, Iqbal S, Reponen T, Mullenberg ML, Thorne PS, Dearborn DG, Morley RL. Mold and endotoxin levels in the aftermath of hurricane Katrina: A pilot project of homes in New Orleans undergoing renovation. Environ Health Perspect 2006;114:1883-9.10.1289/ehp.9258176414917185280
  19. Solomon GM, Hjelmroos-Koski M, Rotkin-Ellman MR, Hammond SK. Airborne mold and endotoxin concentrations in New Orleans, Louisiana, after flooding, Octobar through November 2005. Environ Health Perspect 2006;114:1381-6.10.1289/ehp.9198157005116966092
  20. McCartney HA, Schmechel D, Lacey ME. Aerodynamic diameter of conidia of Alternaria species. Plant Pathol 1993;42:280-6.10.1111/j.1365-3059.1993.tb01501.x
  21. Kildesø J, Würtz H, Nielsen KF, Kruse P, Wilkins K, Thrane U, Gravesen S, Nielson PA, Schneider T. Determination of fungal spore release from wet building materials. Indoor Air 2003;13:148-55.10.1034/j.1600-0668.2003.00172.x12756008
  22. Horner WE, Helbling A, Salvaggio JE, Lehrer SB. Fungal allergens. Clin Microbiol Rev 1995;8:161-79.10.1128/CMR.8.2.1611728547621398
  23. Reponen T, Grinshpun SA, Conwell KL, Wiest J, Anderson M. Aerodynamic versus physical size of spores: measurement and implication for respiratory deposition. Grana 2001:40:119-25.10.1080/00173130152625851
  24. Górny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M, Grinshpun A. Fungal fragments as indoor air biocontaminants. Appl Environ Microbiol 2002;68:3522-31.10.1128/AEM.68.7.3522-3531.200212676712089037
  25. Green BJ, Tovey ER, Sercombe JK, Blachere FM, Beezhold DH, Schmechel D. Airborne fungal fragments and allergenicity. Med Mycol 2006;44(Suppl 1):S245-55.10.1080/13693780600776308
  26. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ 2005;39:5454-65.10.1016/j.atmosenv.2005.05.042
  27. Brasel TL, Douglas DR, Wilson SC, Straus DC. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol 2005;71:114-22.10.1128/AEM.71.1.114-122.2005
  28. Seo SC, Reponen T, Levin L, Grinshpun SA. Size-fractionated (1→3)-β-D-glucan concentrations aerosolized from different moldy building materials. Sci Total Environ 2009;407:806-14.10.1016/j.scitotenv.2008.10.018
  29. Reponen T, Seo SC, Grimsley F, Lee T, Crawford C, Grinshpun SA. Fungal fragments in moldy houses: a field study in homes in New Orleans and South Ohio. Atmos Environ 2007;41:8140-9.10.1016/j.atmosenv.2007.06.027
  30. Meklin T, Reponen T, Toivola M, Koponen V, Husman T, Hyvärinen A, Nevalainen A. Size distributions of airborne microbes in moisture-damaged and reference school buildings of two construction types. Atmos Environ 2002;36:6031-9.10.1016/S1352-2310(02)00769-0
  31. Green BJ, Sercombe JK, Tovey ER. Fungal fragments and undocumented conidia function as new aeroallergen source. J Allergy Clin Immunol 2005;115:1043-8.10.1016/j.jaci.2005.02.009
  32. Sporik RB, Arruda LK, Woodfolk J, Chapman MD, Platts-Mills TAE. Environmental exposure to Aspergillus fumigatus allergen (Asp f I). Clin Exp Allergy 1993;23:326-31.10.1111/j.1365-2222.1993.tb00330.x
  33. Kurup VP, Shen HD, Banerjee B. Respiratory fungal allergy. Microbes Infect 2000;2:1101-10.10.1016/S1286-4579(00)01264-8
  34. Ronning CM, Fedorova ND, Bowyer P, Coulson R, Goldman G, Kim HS, Turner G, Wortman JR, Yu J, Anderson MJ, Denning DW, Nierman WC. Genomics of Aspergillus fumigatus. Rev Iberoam Micol 2005;22:223-8.10.1016/S1130-1406(05)70047-4
  35. Abad A, Fernández-Molina JV, Bikandi J, Ramirez A, Margareto J, Sendino J, Hernando FL, Pontón J, Garaizar J, Rementeria A. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 2010:27:155-82.10.1016/j.riam.2010.10.003
  36. Latgé JP, Moutaouakil M, Debeaupuis JP, Bouchara JP, Haynes K, Prévost MC. The 18-kilodalton antigen secreted by Aspergillus fumigatus. Infect Immun 1991;59:2586-94.10.1128/iai.59.8.2586-2594.1991
  37. Arruda LK, Mann BJ, Chapman MD. Selective expression of a major allergen and cytotoxin, Asp f 1, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus related diseases. J Immunol 1992;149:3354-9.
  38. Rementeria A, López-Molina N, Ludwig A, Vivanco AB, Bikandi J, Pontón J. Garaizar J. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 2005;22:1-23.10.1016/S1130-1406(05)70001-2
  39. Madan T, Priyadarsiny P, Vaid M, Kamal N, Shah A, Haq W, Bandacharya Katti S, Usha Sarma P. Use of a synthetic peptide epitope of Asp f 1, a major allergen or antigen of Aspergillus fumigatus, for improved immunodiagnosis of allergenic bronchopulmonary aspergillosis. Clin Diagn Lab Immunol 2004;11:552-8.10.1128/CDLI.11.3.552-558.2004
  40. Latgé JP. Aspergillus fumigatus and Aspergillosis. Clin Microbiol Rev 1999;12:310-50.10.1128/CMR.12.2.310
  41. Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope ortologues. BMC Genomics 2006;7:251-64.10.1186/1471-2164-7-251
  42. Glaser AG, Kirsch AI, Zeller S, Menz G, Rhyner C, Crameri R. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergillus fumigatus. Allergy 2009;64:1144-51.10.1111/j.1398-9995.2009.02029.x
  43. Benndorf D, Müller A, Bock K, Manuwald O, Herbarth O, von Bergen M. Identification of spore allergens from the indoor mould Aspergillus versicolor. Allergy 2008;63:454-60.10.1111/j.1398-9995.2007.01603.x
  44. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227-34.10.1016/j.jaci.2003.11.023
  45. Asturias JA, Arilla MC, Ibarrola I, Eraso E, González-Rioja R, Martinez A. A sensitive two-site enzyme-linked immunosorbent assay for measurement of the major Alternaria alternata allergen Alt a 1. Ann Allergy Asthma Immunol 2003;90:529-35.10.1016/S1081-1206(10)61846-7
  46. Kleine-Tebbe J, Worm N, Jeep S, Mathiessen F, Lowenstein H, Kungel G. Predominance of the major allergen (Alt a 1) in Alternaria sensitized patients. Clin Exp Allergy 1993;23:211-8.10.1111/j.1365-2222.1993.tb00884.x
  47. Postigo I, Gutiánrez-Rodriguez A, Fernández J, Guisantes JA, Suňén E, Martinez J. Diagnostic value of Alt a 1, fungal enolase and manganese-dependent superoxide dismutase in the component-resolved diagnosis of allergy to pleosporaceae. Clin Exp Allergy 2011:41:443-51.10.1111/j.1365-2222.2010.03671.x
  48. Gutiérrez-Rodriguez A, Postigo I, Guisantes JA, Suňén E, Martinez J. Identification of allergens homologous to Alt a 1 from Stemphylium botryosum and Ulocladium botrytis. Med Mycol 2011. (doi:10.3109/13693786.2011.576350)
  49. Schmechel D, Simpson JP, Beezhold D, Lewis DM. The development of species-specific immunodiagnostics for Stachybotrys chartarum: The role of cross-reactivity. J Immunol Methods 2006;309:150-9.10.1016/j.jim.2005.12.001
  50. Kurup VP, Banerjee B. Fungal allergens and peptide epitopes. Peptides 2000;21:589-99.10.1016/S0196-9781(00)00181-9
  51. Crameri R, Zeller S, Glaser AG, Vilhelmsson M, Rhyner C. Cross-reactivity among fungal allergens: a clinically relevant phenomenon? Mycoses 2008;52:99-106.10.1111/j.1439-0507.2008.01644.x18983424
  52. Mitakakis TZ, Barnes C, Tovey ER. Spore germination increases allergen release from Alternaria. J Allergy Clin Immunol 2001;107:388-90.10.1067/mai.2001.11260211174210
  53. Green BJ, MitakakisTZ, Tovey ER. Allergen detection from 11 fungal species before and after germination. J Allergy Clin Immunol 2003;111:285-9.10.1067/mai.2003.5712589346
  54. Portnoy JM, Barnes CS, Kennedy K. Sampling for indoor fungi. J Allergy Clin Immunol 2004;113:189-98.10.1016/j.jaci.2003.11.02114767427
  55. Tovey ER, Green BJ. Measuring environmental fungal exposure. Med Mycol 2005;43(Suppl 1):S67-70.10.1080/1369378040002009716110794
  56. Dillon KH, Boling DK, Miller JD. Comparison of detection methods for Aspergillus fumigatus in environmental air samples in an occupational environment. J Occup Environ Hyg 2007;4:509-13.10.1080/1545962070140401317503296
  57. Adhikari A, Jung J, Reponen T, Lewis JS, DeGrasse EC, Grimsley LF, Chew GL, Grinshpun SA. Aerosilization of fungi, (1→3)-β-D glucan, and endotoxin from flood-affected materials collected in New Orleans homes. Environ Res 2009;109:215-24.10.1016/j.envres.2008.12.010440142519201399
  58. Chew GL, Rogers C, Burge HA, Muilenberg ML, Gold DR. Dustborne and airborne fungal propagules represent a different spectrum of fungi with differing relations to home characteristics. Allergy 2003;58:13-20.10.1034/j.1398-9995.2003.00013.x12580801
  59. Laumbach RJ, Kipen HM. Bioaerosols and sick building syndrome: particles, inflammation, and allergy. Curr Opin Allergy Clin Immunol 2005;5:135-9.10.1097/01.all.0000162305.05105.d015764903
  60. Goebes MD, Boehm AB, Hildemann LM. Contributions of foot traffic and outdoor concentrations to indoor airborne Aspegillus. Aerosol Sci Technol 2011;45:352-63.10.1080/02786826.2010.537712
  61. Goebes MD, Baron EJ, Mathews KL, Hildemann LM. Effect of building construction on Aspergillus concentrations in a hospital. Infect Control Hosp Epidemiol 2008;29:462-4.10.1086/58718918419373
  62. Pitkäranta M, Meklin T, Hyvärinen A, Paulin L, Auvinen P, Nevalainen A, Rintala H. Analysis of fungal flora in indoor dust by ribosomal DNA sequence analysis, quantitative PCR, and culture. Appl Environ Microbiol 2008;74:233-44.10.1128/AEM.00692-07222322317981947
  63. Green BJ, Schmechel D, Sercombe JK, Tovey ER. Enumeration and detection of aerosolized Aspergillus fumigatus and Penicillium chrysogenum conidia and hyphae using a novel double immunostaining technique. J Immunol Methods 2005;307:127-34.10.1016/j.jim.2005.10.00116280129
  64. Salo PM, Arbes SJ Jr, Crockett PW, Thorne PS, Cohn RD, Zeldin DC. Exposure to multiple indoor allergens in US homes and its relationship to asthma. J Allergy Clin Immunol 2008;121:678-84.10.1016/j.jaci.2007.12.1164237612118255132
  65. Schmechel D, Green BJ, Blachere FM, Janotka E, Beezhold DH. Analytical bias of cross-reactive polyclonal antibodies for environmental immunoassays of Alternaria alternata. J Allergy Clin Immunol 2008;121:763-8.10.1016/j.jaci.2007.09.04618036643
  66. Schmechel D, Simpson JP, Lewis DM. The production and characterization of monoclonal antibodies to the fungus Aspergillus versicolor. Indoor Air 2005;15(Suppl 9):11-9.10.1111/j.1600-0668.2005.00340.x15910525
  67. Abebe M, Kumar V, Rajan S, Thaker A, Sevinc S, Vijay HM. Detection of recombinant Alt a1 in a two-site, IgM based, sandwich ELISA opens up possibilities of developing alternative assays for the allergens. J Immunol Methods 2006;312:111-7.10.1016/j.jim.2006.03.00416687154
  68. Prester Lj, Macan J. Determination of Alt a 1 (Alternaria alternata) in poultry farms and a sawmill using ELISA. Med Mycol 2010;48:298-301.10.3109/13693780903115402
  69. Prester Lj, Macan J, Matković K, Vučemilo M. Determination of Aspergillus fumigatus allergen 1 in poultry farms using the enzyme immunoassay. Arh Hig Rada Toksikol 2010;61:167-73.10.2478/10004-1254-61-2010-200420587390
  70. Ryan TJ, Whitehead LW, Connor TH, Burau KD. Survey of the Asp f 1 allergen in office environments. Appl Occup Environ Hyg 2001;16:679-84.10.1080/1047322011908911414518
  71. Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001;107:641-6.10.1067/mai.2001.11411811295652
  72. Loo CK, Foty RG, Wheeler AJ, Miller JD, Evans G, Stieb DM, Dell SD. Do questions reflecting indoor air pollutant exposure from a questionnaire predict direct measure of exposure in owner-occupied houses? Int J Environ Res Public Health 2010;7:3270-97.10.3390/ijerph7083270295458120948960
  73. Noss I, Wouters IM, Bezemer G, Metwali N, Sander I, Raulf-Heimsoth M, Heederik DJJ, Thorne PS, Doekes G. β-(1,3)-Glucan exposure assessment by passive airborne dust sampling and new sensitive immunoassays. Appl Environ Microbiol 2010;76:1158-67.10.1128/AEM.01486-09282094420038709
  74. Foto M, Vrijmoed LLP, Miller JD, Ruest K, Lawton M, Dales RE. A comparison of airborne ergosterol, glucan and Air-O-Cell data in relation to physical assessments of mold damage and some other parameters. Indoor Air 2005;15:257-66.10.1111/j.1600-0668.2005.00370.x15982272
  75. Douwes J, Siebers R, Wouters IM, Doekes G, Fitzharris P, Crane J. Endotoxin, (1→3)-β-D-glucans and fungal extra-cellular polysaccharides in New Zealand homes: a pilot study. Ann Agric Environ Med 2006;13:361-5.
  76. Salare VR, Hinde CA, Miller JD. Analysis of settled dust in homes and fungal glucan in air particulate collected during HEPA vacuuming. Indoor Built Environ 2009;18:485-91.10.1177/1420326X09341343
  77. Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009;22:535-51.10.1128/CMR.00014-09277236119822887
  78. Latgé JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001;9:382-9.10.1016/S0966-842X(01)02104-7
  79. Osborne M, Reponen T, Adhikari A, Cho SH, Grinshpun SA, Levin L, Bernstein DI, LeMasters G. Specific fungal exposures, allergic sensitization, and rhinitis in infants. Pediatr Allergy Immunol 2006;17:450-7.10.1111/j.1399-3038.2006.00414.x
  80. Salo PM, Arbes SJ Jr, Sever M, Jaramillo R, Cohn RD, London SJ, Zeldin DC. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J Allergy Clin Immunol 2006;118:892-8.10.1016/j.jaci.2006.07.037
  81. Stark PC, Celedón JC, Chew GL, Ryan LM, Burge HA, Muilenberg ML, Gold DR. Fungal levels in the home and allergic rhinitis by 5 years of age. Environ Health Perspect 2005;113:1405-9.10.1289/ehp.7844
  82. Gent JF, Ren P, Belanger K, Triche E, Bracken MB, Holford TR, Leaderer BP. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect 2002;110:A781-6.10.1289/ehp.021100781
  83. Wüethrich B. Epidemiology of allergic diseases: are they really on the increase? Int Arch Allergy Appl Immunol 1989:90(Suppl 1):3-10.10.1159/000235067
  84. Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, Carlsen KH, van Cauwenberge P, Darsow U, Fokkens WJ, Haahtela T, van Hoecke H, Jessberger B, Kowalski ML, Kopp T, Lahoz CN, Lodrup Carlsen KC, Papadopoulos NG, Ring J, Schmid-Grendelmeier P, Vignola AM, Wöhrl S, Zuberbier T. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GA2LEN network. Allergy 2005;60:1287-300.10.1111/j.1398-9995.2005.00895.x
  85. Pasanen P, Korpi A, Kalliokoski P, Pasanen AL. Growth and volatile metabolite production of Aspergillus versicolor in house dust. Environ Int 1997;23:425-32.10.1016/S0160-4120(97)00027-5
  86. Pongracic JA, O'Connor GT, Muilenberg ML, Vaughn B, Gold DR, Kattan M, Morgan WJ, Gruchalla RS, Smartt E, Mitchell HE. Different effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children. J Allergy Clin Immunol 2010;125:593-9.10.1016/j.jaci.2009.10.036475410920132971
  87. Katz Y, Verleger H, Barr J, Rachmiel M, Kiviti S, Kuttin ES. Indoor survey of moulds and prevalence of mould atopy in Israel. Clin Exp Allergy 1999;29:186-92.10.1046/j.1365-2222.1999.00403.x10051722
  88. Crameri R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002;19:151-7.10.1183/09031936.02.00229102
  89. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998;10:1211-6.10.1093/intimm/10.8.1211
  90. Fricker-Hidalgo H, Coltey B, Llerena C, Renversez JC, Grillot R, Pin I, Pelloux H, Pinel C. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol 2010;17:1330-6.10.1128/CVI.00200-10
  91. Nielsen KF. Mycotoxin production by indoor molds. Fungal Genet Biol 2003;39:103-17.10.1016/S1087-1845(03)00026-4
  92. Jarvis BB, Miller JD. Mycotoxins as harmful indoor air contaminants. Appl Microbiol Biotechnol 2005;66:367-72.10.1007/s00253-004-1753-9
  93. Piecková E, Hurbánková M, Černá S, Lišková A, Kováčiková Z, Kolláriková Z, Wimmerová S. Inflammatory and haematotoxic potential of indoor Stachybotrys chartarum (Ehrenb.) hughes metabolites. Arh Hig Rada Toksikol 2009;60:401-9.10.2478/10004-1254-60-2009-1971
  94. Saijo Y, Nakagi Y, Ito T, Sugioka Y, Endo H, Yoshida T. Relation of dampness to sick building syndrome in Japanese public apartment houses. Environ Health Prev Med 2009;14:26-35.10.1007/s12199-008-0052-y
  95. Li D, Chin S. Yang. Fungal contamination as a major contributor to sick building syndrome. Adv Appl Microbiol 2004;55:31-112.10.1016/S0065-2164(04)55002-5
  96. Schwab CJ, Straus DC. The roles of Penicillium and Aspergillus in sick building syndrome. Adv Appl Microbiol 2004;55:215-38.10.1016/S0065-2164(04)55008-6
  97. Hiipakka DW, Buffington JR. Resolution of sick building syndrome in a high-security facility. Appl Occup Environ Hyg 2000:15:635-43.10.1080/1047322005007564410957819
  98. Douwes J. (1→ 3)-β-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 2005;15:160-9.10.1111/j.1600-0668.2005.00333.x15865616
  99. Chen J, Seviour R. Medicinal importance of fungal β-(1→ 3), (1→ 6)-glucans. Mycol Res 2007;111:635-52.10.1016/j.mycres.2007.02.01117590323
DOI: https://doi.org/10.2478/10004-1254-62-2011-2126 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Slovenian
Page range: 371 - 380
Published on: Dec 25, 2011
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2011 Ljerka Prester, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 62 (2011): Issue 4 (December 2011)